Biogen Inc. (IDP.DE)
Develops medicines for neurological diseases like multiple sclerosis and Alzheimer's
189.72+0.07%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+73.7%
The outlook
The stock trades near its 52-week highs, sitting well above both its 50- and 200-day moving averages. At a trailing P/E of 23.2, it commands a moderate valuation premium. Analyst sentiment leans constructive, though current momentum is flat.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range96% of the way from its 52-week low to high
Market cap
$28.01B
52-wk high
193.00
52-wk low
108.80
50-day avg
165.80
200-day avg
151.16
Trailing P/E
23.2